IMVT
Immunovant Inc
$28.8
Earnings Summary
Revenue | $0Mn |
Net Profits | $-51.42Mn |
Net Profit Margins | -Inf% |
Highlights
Immunovant Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q4 2023. On a quarterly growth basis, Immunovant Inc has generated NaN% jump in its revenue since last 3-months.
Immunovant Inc’s net profit jumped 18.68% since last year same period to $-51.42Mn in the Q4 2023. On a quarterly growth basis, Immunovant Inc has generated 12.35% jump in its net profits since last 3-months.
Immunovant Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q4 2023. On a quarterly growth basis, Immunovant Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Immunovant Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.43 |
EPS Estimate Current Year | -0.43 |
Highlights
Immunovant Inc’s earning per share (EPS) estimates for the current quarter stand at -0.43 - a 0% jump from last quarter’s estimates.
Immunovant Inc’s earning per share (EPS) estimates for the current year stand at -0.43.
Key Ratios
Key ratios of the Immunovant Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.36 |
Highlights
Immunovant Inc’s earning per share (EPS) jumped 26.53% since last year same period to -0.36 in the Q4 2023. This indicates that the Immunovant Inc has generated 26.53% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-05-22 | -0.43 | -0.46 | -6.98% |
2024-02-12 | -0.43 | -0.36 | 16.28% |
2023-11-09 | -0.47 | -0.45 | 4.26% |
2023-08-10 | -0.45 | -0.57 | -26.67% |
₹0 US Stocks a/c Opening Fee